share

Schizophrenia Overview
Payer Considerations in Managing Schizophrenia Relapse Reduction

This video teaser highlights the full-length version of a brief informational video presentation for payers that aims to inform on clinical and payer market dynamics as they relate to schizophrenia relapse reduction and that discusses long-acting injectables as a treatment option.

Frameworks resources are intended for educational purposes only and are intended for healthcare professionals and/or payer representatives. They are not intended as, nor are they a substitute for, medical care, advice, or professional diagnosis. Healthcare professionals should use independent medical judgment when considering Frameworks educational resources. Those seeking medical advice should consult with a healthcare professional. Frameworks resources are not intended as reimbursement or legal advice. Users should seek independent, qualified professional advice to ensure their organization is in compliance with the complex legal and regulatory requirements governing healthcare services, and that treatment decisions are made consistent with the applicable standards of care. Frameworks is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.